Cocrystal Pharma
COCP
27 hedge funds and large institutions have $1.17M invested in Cocrystal Pharma in 2026 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 3 increasing their positions, 7 reducing their positions, and 6 closing their positions.
49% more capital invested
Capital invested by funds: $784K → $1.17M (+$384K)
17% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 6
4% more funds holding
Funds holding: 26 → 27 (+1)
2.43% more ownership
Funds ownership: 5.63% → 8.07% (+2.4%)
57% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Two Sigma Investments
New York
|
+$216K |
| 2 |
Vanguard Capital Management
Malvern,
Pennsylvania
|
+$146K |
| 3 |
Renaissance Technologies
New York
|
+$68.5K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$55.5K |
| 5 |
HF
HRT Financial
New York
|
+$25K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TC
T3 Companies
New York
|
-$52K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
-$17.3K |
| 3 |
TSS
Two Sigma Securities
New York
|
-$15.4K |
| 4 |
VF
Virtu Financial
New York
|
-$13K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$8.23K |
COCP Hedge Fund Activity: Q2 2026 in Review
27 of the 8,303 institutional investors tracked by Wall St. Rank reported a position in Cocrystal Pharma (COCP) for Q2 2026, worth a combined $1.17M — up 49% from $784K a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new COCP positions and 6 closed out — a net gain of 1 holder — while 3 added to existing stakes and 7 trimmed.
The largest buyer was Two Sigma Investments, opening a new position worth an estimated $216K. The largest seller was T3 Companies, exiting entirely with an estimated $52K sold.
- 27 institutional investors held Cocrystal Pharma (COCP) as of Q2 2026, up from 26 in Q1 2026.
- Funds reported $1.17M of Cocrystal Pharma stock for Q2 2026, up 49% quarter-over-quarter.
- 7 funds opened new Cocrystal Pharma positions in Q2 2026 and 6 closed out, a net change of +1 holder.
- The largest Cocrystal Pharma buyer in Q2 2026 was Two Sigma Investments, an estimated $216K added.
- The largest Cocrystal Pharma seller in Q2 2026 was T3 Companies, an estimated $52K sold.
Based on aggregated 13F filings for Q2 2026.